Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Track-1 (Emerald 2): Synthesis & Screening of Drugs & Phytochemicals

Track-1 (Emerald 2): Synthesis & Screening of Drugs & Phytochemicals Agenda



Co-Located Conference Agendas

Indian Lab Automation | Drug Discovery India 2014 | Drug Metabolism & Discovery ADMET | 


Other Track Agendas

Track-1 (Emerald 2): Synthesis & Screening of Drugs & Phytochemicals | Track-2 (Emerald 3): Chemical Biology Approaches to Drug Discovery | 

Print Agenda

Thursday, 11 September 2014

08:00

Registration

09:15

Inauguration

09:20

Chairman's Welcome and Inaugural Talk

09:30

Renaissance in Pharmacognosy:The Need is Great and the Time is Now
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America

10:15

Memento Presentation

10:25

Coffee Break and Networking in Exhibition Area


SESSION 1: Advances in Organic and Medicinal Chemistry

10:55

Asit ChakrabortiKeynote Presentation

Novel Anti-Inflammatory Scaffolds through Sustainable Chemistry
Asit Chakraborti, Professor and Head, National Institute of Pharmaceutical Education and Research, India

11:30

Novel Heterocyclic Construction Using N-Heterocyclic Carbene Organocatalysis
Akkattu Biju, Senior Scientist, National Chemical Laboratory, India

12:00

DNA-Targeted Anticancer Agents: Molecular Design and their Synthesis
N Shankaraiah, Assistant Professor, NIPER, Hyderabad, India

12:30

Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells
Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy, India

13:00

Advanced Chemistry Development IncTechnology Spotlight:
Drug Discovery & Development: The Dilemma of Investing in Software Solutions
K K Bhagchandani, Director, Advanced Chemistry Development Inc

13:15

Lunch and Networking in Exhibition Area


SESSION 2: Drug Discovery and Development: Solution to Health Issues

14:15

Anamik ShahKeynote Presentation

Collaborative Drug Research in India: Opportunity and Challenges in Global Perspectives
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

14:50

Dundee, Drug Discovery Unit: Novel Targets and Small Molecule Inhibitors
Ian Gilbert, Head of Chemistry, University of Dundee, United Kingdom

15:20

Coffee Break and Networking in Exhibition Area


SESSION 3: Chemoinformatics Approaches to Virtual Screening

15:40

G SastryKeynote Presentation

Modeling Specificity in Lead Optimization
G Sastry, Scientist and Head, Indian Institute of Chemical Technology, India

16:15

Open-Source Chemoinformatics for Virtual Screening in Drug Discovery
Muthukumarasamy Karthikeyan, Principal Scientist, National Chemical Laboratory, India

16:45

Pharmacophore Modeling and Molecular Docking Based Thriving Protocol for Target Identification
Vijay Masand, Assistant Professor, Vidya Bharti College, India

17:15

End of First Day of Conference

17:30

FREE WORKSHOP: RNA Silencing for Drug Discovery- Challenges and Strategies

Friday, 12 September 2014


SESSION 4: Natural Products and Phytochemical Screening-Recent Trends

09:00

Ashok VaidyaKeynote Presentation

Reverse Pharmacology (RP)- A Paradigm Shift for Drug Discovery and Development
Ashok Vaidya, Research Director, Kasturba Health Society, India

09:35

Special Lecture: Moving from Single Drug to Formulation Discovery
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India

10:05

Natural Products for Drug Discovery and Development: Inspiration from the " Ancient Wisdom of Mother Nature"
Mukund Chorghade, President & CSO, Chorghade Enterprises, United States of America

10:35

Coffee Break and Networking in Exhibition Area

10:55

"NMITLI Arthritis Model" (Validating Ayurvedic Drugs for Global Use)
Arvind Chopra, Director and Chief Rheumatologist, Center for Rheumatic Diseases, India

11:25

Natural Products as New Sources of Drug and Nutraceutical Discovery
Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd, India


SESSION 5: Optimizing Leads using Advanced Technologies

11:55

Plenary Presentation: High-throughput In vivo Vertebrate Screening: An Automation Point of View
Giancarlo Basile, Editor in Chief, Current Research in Drug Discovery, Italy

12:25

Discovery of Novel Compounds for the Treatment of Drug Resistant and Persistent Tuberculosis
Rajkumar Halder, Scientist E, Translational Health Science and Technology Institute, India

12:55

High Content Image- Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Multiple Highly Pathogenic RNA Viruses
Krishna Kota, Scientist, PerkinElmer, United States of America

13:25

Freeslate IncTechnology Spotlight:
Leveraging the Power of High Throughput Screening to Identify a Diastereomeric Salt for Chiral Resolution
David Yamane, Product Marketing Director, Freeslate Inc

13:40

Lunch and Networking in Exhibition Area

14:20

POSTER EVALUATION


SESSION 6: Collaborative and Open Source Drug Discovery

14:40

Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery, United States of America

15:10

Opportunities for Strategic Research Partnerships in Drug Discovery
Ajith Kamath, Head, Pfizer Inc, India

15:40

Crowdsourcing Systems Level Platforms for Open Source Drug Discovery
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit, India

16:00

Open Source Drug Discovery for Tuberculosis: Lessons to learn
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

16:20

Open Discussion on Open Source Drug Discovery

16:40

Coffee Break and Networking in Exhibition Area

16:55

Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020

17:30

End of the Conference


Agenda is not currently available
Add to Calendar ▼2014-09-11 00:00:002014-09-12 00:00:00Europe/LondonTrack-1 (Emerald 2): Synthesis and Screening of Drugs and PhytochemicalsSELECTBIOenquiries@selectbiosciences.com